indomethacin has been researched along with Colitis, Granulomatous in 39 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Rats with indomethacin-induced enteritis were orally administered Rb, Mn, and Zn as tracers." | 7.72 | Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model. ( Imaseki, H; Joshima, H; Nakao, K; Saito, Y; Suzuki, Y; Tamanoi, I, 2004) |
| "Although anti-TNF treatment suppresses inflammation and restores gut barrier function in patients with CD, it does not antagonize the barrier hyperresponsiveness to indomethacin." | 3.73 | Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent. ( Bulteel, V; Noman, M; Rutgeerts, P; Suenaert, P; Van Assche, G; Vermeire, S, 2005) |
| " Rats with indomethacin-induced enteritis were orally administered Rb, Mn, and Zn as tracers." | 3.72 | Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model. ( Imaseki, H; Joshima, H; Nakao, K; Saito, Y; Suzuki, Y; Tamanoi, I, 2004) |
| "Ulcerative colitis (UC) and Crohn's disease (CD) are two major forms of inflammatory bowel disease (IBD)." | 1.91 | Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats. ( Gruneck, L; Phunikhom, K; Popluechai, S; Sattayasai, J; Sharpton, TJ; Thipart, K, 2023) |
| "Crohn's disease is a type of inflammatory bowel disease of unknown etiology." | 1.51 | Elemental Diet Regulates Intestinal Permeability and Antibody Production in Indomethacin-Induced Intestinal Injury Rats. ( Akahoshi, A; Kikuchi, Y; Matsuo, M; Minami, H; Nabeta, C, 2019) |
| "Crohn's disease is a common inflammatory manifestation in humans and other animal species relating to the ulceration and digestive disturbances in upper gastro-intestinal tract." | 1.43 | Emu oil offers protection in Crohn's disease model in rats. ( Pandiyan, V; Selvasubramanian, S; Vemu, B, 2016) |
| "Treatment with sulfasalazine, low dose of natrexone or their combination resulted in significant improvement of all measured parameters compared with enteritis group." | 1.43 | Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats. ( Abdel-Salam, LO; Kamel, MM; Khattab, A; Osman, AS; Tawfik, DI; Tolba, HM, 2016) |
| " Teduglutide, a recombinant human GLP2 variant (GLP2-2G), has increased half-life and stability as compared to the native GLP2 peptide, but still requires twice daily dosing in preclinical models and daily dosing in the clinic." | 1.38 | GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model. ( Alters, SE; Lachinyan, T; McLaughlin, B; Podust, V; Schellenberger, V; Spink, B; Stemmer, WP; Wang, CW, 2012) |
| "First, patients with quiescent Crohn's disease and ulcerative colitis received the non-NSAID analgesic acetaminophen (n = 26) and the conventional NSAIDs naproxen (n = 32), diclofenac (n = 29), and indomethacin (n = 22) for 4 weeks." | 1.33 | Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. ( Bjarnason, I; Bjornsson, E; Maiden, L; Premchand, P; Sherwood, R; Smale, S; Takeuchi, K; Thjodleifsson, B, 2006) |
| " Pinane thromboxane, a selective thromboxane synthase inhibitor and receptor blocker, inhibited OxAA stimulation of TXB(2) and IL-8 in a dose-response manner." | 1.32 | Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. ( Alzoghaibi, MA; Fowler, AA; Graham, MF; Walsh, SW; Willey, A; Yager, DR, 2004) |
| "Both Crohn's disease ileal ulcers and indomethacin-induced jejunal ulcers in the rat have a predilection for the mesenteric margin of the bowel wall." | 1.31 | Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. ( Anthony, A; Dhillon, AP; Pounder, RE; Wakefield, AJ, 2000) |
| "Metronidazole was more potent than amoxicillin/clavulanic acid and anti-tumour necrosis factor in improving the indometacin-induced small bowel inflammation." | 1.31 | Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model. ( Ceuppens, JL; Colpaert, S; De Greef, B; Geboes, K; Liu, Z; Rutgeerts, P, 2001) |
| "Crohn's disease (CD) and ulcerative colitis (UC) represent clinically distinct chronic inflammatory bowel diseases (IBD) of unknown etiology." | 1.29 | Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis. ( Gurbindo, C; Justinich, C; Marchand, R; Menezes, J; Sabbah, S; Seidman, EG, 1993) |
| "Finally, supernatants from Crohn's disease and ulcerative colitis cell cultures failed to suppress interleukin-2 production by control CD4+ T cells." | 1.28 | Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. ( Fiocchi, C; Kusugami, K; Matsuura, T; Rachmilewitz, D; West, GA; Youngman, KR, 1991) |
| "Patients with colitis or ileocolitis were more likely to suffer from ocular inflammation (23." | 1.28 | Ocular inflammation in Crohn's disease. ( Murray, AD; Salmon, JF; Wright, JP, 1991) |
| "One patient had ulcerative colitis, while two patients had Crohn's disease." | 1.27 | Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. ( Brewster, AC; Darrah, JJ; Heilpern, RJ; Patwardhan, RV, 1983) |
| "Mucosal tissue of patients with Crohn's disease synthesized considerably more LTB4 and sulfidopeptide-leukotrienes than non-inflamed mucosa." | 1.27 | [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. ( Dreyling, KW; Hoppe, U; Kozuschek, W; Morgenroth, K; Peskar, BA; Peskar, BM, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (28.21) | 18.7374 |
| 1990's | 8 (20.51) | 18.2507 |
| 2000's | 13 (33.33) | 29.6817 |
| 2010's | 6 (15.38) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Thipart, K | 2 |
| Gruneck, L | 2 |
| Phunikhom, K | 2 |
| Sharpton, TJ | 2 |
| Sattayasai, J | 2 |
| Popluechai, S | 2 |
| Kikuchi, Y | 1 |
| Matsuo, M | 1 |
| Nabeta, C | 1 |
| Akahoshi, A | 1 |
| Minami, H | 2 |
| Alters, SE | 2 |
| McLaughlin, B | 2 |
| Spink, B | 2 |
| Lachinyan, T | 2 |
| Wang, CW | 2 |
| Podust, V | 2 |
| Schellenberger, V | 2 |
| Stemmer, WP | 2 |
| Vemu, B | 1 |
| Selvasubramanian, S | 1 |
| Pandiyan, V | 1 |
| Simon, H | 1 |
| Fischer, T | 1 |
| Almási, A | 1 |
| Fischer, E | 1 |
| Tawfik, DI | 1 |
| Osman, AS | 1 |
| Tolba, HM | 1 |
| Khattab, A | 1 |
| Abdel-Salam, LO | 1 |
| Kamel, MM | 1 |
| Jeffers, M | 1 |
| McDonald, WF | 1 |
| Chillakuru, RA | 1 |
| Yang, M | 1 |
| Nakase, H | 1 |
| Deegler, LL | 1 |
| Sylander, ED | 1 |
| Rittman, B | 1 |
| Bendele, A | 1 |
| Sartor, RB | 1 |
| Lichenstein, HS | 1 |
| Houchen, CW | 1 |
| Ruh, J | 1 |
| Schmidt, E | 1 |
| Gebhard, MM | 1 |
| Klar, E | 1 |
| Glaser, F | 1 |
| Herfarth, C | 1 |
| Krieglstein, CF | 1 |
| Anthoni, C | 1 |
| Laukötter, MG | 1 |
| Spiegel, HU | 1 |
| Schmid, KW | 1 |
| Schürmann, G | 1 |
| Alzoghaibi, MA | 1 |
| Walsh, SW | 1 |
| Willey, A | 1 |
| Yager, DR | 1 |
| Fowler, AA | 1 |
| Graham, MF | 1 |
| Nakao, K | 1 |
| Suzuki, Y | 1 |
| Imaseki, H | 1 |
| Joshima, H | 1 |
| Tamanoi, I | 1 |
| Saito, Y | 1 |
| Suenaert, P | 2 |
| Bulteel, V | 2 |
| Vermeire, S | 1 |
| Noman, M | 1 |
| Van Assche, G | 1 |
| Rutgeerts, P | 4 |
| Suzuki, H | 1 |
| Hanyou, N | 1 |
| Sonaka, I | 1 |
| Takeuchi, K | 1 |
| Smale, S | 1 |
| Premchand, P | 1 |
| Maiden, L | 1 |
| Sherwood, R | 1 |
| Thjodleifsson, B | 1 |
| Bjornsson, E | 1 |
| Bjarnason, I | 1 |
| Sido, B | 1 |
| Seel, C | 1 |
| Hochlehnert, A | 1 |
| Breitkreutz, R | 1 |
| Dröge, W | 1 |
| Klopcic, B | 1 |
| Appelbee, A | 1 |
| Raye, W | 1 |
| Lloyd, F | 1 |
| Jooste, JC | 1 |
| Forrest, CH | 1 |
| Lawrance, IC | 1 |
| Cury, DH | 1 |
| Costa, JE | 1 |
| Irika, K | 1 |
| Mijji, L | 1 |
| Garcez, A | 1 |
| Buchiguel, C | 1 |
| Silva, I | 1 |
| Sipahi, A | 1 |
| Holdstock, G | 2 |
| Chastenay, BF | 1 |
| Krawitt, EL | 2 |
| Ershler, WB | 1 |
| Victorino, RM | 1 |
| Patwardhan, RV | 1 |
| Heilpern, RJ | 1 |
| Brewster, AC | 1 |
| Darrah, JJ | 1 |
| Goodacre, RL | 1 |
| Bienenstock, J | 1 |
| D'Haens, G | 1 |
| Hiele, M | 2 |
| Geboes, K | 2 |
| Ceuppens, JL | 2 |
| Gurbindo, C | 1 |
| Sabbah, S | 1 |
| Menezes, J | 1 |
| Justinich, C | 1 |
| Marchand, R | 1 |
| Seidman, EG | 1 |
| Duda, SH | 1 |
| Raible, RT | 1 |
| Risler, T | 1 |
| Huppert, PE | 1 |
| Brambs, HJ | 1 |
| Gregor, M | 1 |
| McCartney, SA | 1 |
| Mitchell, JA | 1 |
| Fairclough, PD | 1 |
| Farthing, MJ | 1 |
| Warner, TD | 1 |
| Anthony, A | 1 |
| Pounder, RE | 1 |
| Dhillon, AP | 1 |
| Wakefield, AJ | 1 |
| Den Hond, E | 1 |
| Peeters, M | 1 |
| Monsuur, F | 1 |
| Ghoos, Y | 1 |
| Colpaert, S | 1 |
| Liu, Z | 1 |
| De Greef, B | 1 |
| Kusugami, K | 1 |
| Matsuura, T | 1 |
| West, GA | 1 |
| Youngman, KR | 2 |
| Rachmilewitz, D | 1 |
| Fiocchi, C | 2 |
| Salmon, JF | 1 |
| Wright, JP | 1 |
| Murray, AD | 1 |
| Holman, RT | 1 |
| Peskar, BM | 1 |
| Kozuschek, W | 1 |
| Morgenroth, K | 1 |
| Hoppe, U | 1 |
| Dreyling, KW | 1 |
| Peskar, BA | 1 |
| Miura, M | 1 |
| Hiwatashi, N | 1 |
| Tubbs, RR | 1 |
| Hart, FD | 1 |
| Fusco, FA | 1 |
| Azzolini, A | 1 |
| Dolcino, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Free Aminoacids in Saliva as A Diagnostic Biomarker of Periodontal Disease[NCT04642716] | 60 participants (Actual) | Interventional | 2015-04-20 | Completed | |||
| Effect of High Omega-3 Fish Intake on Lipid Peroxidation[NCT01183520] | 30 participants (Actual) | Interventional | 2010-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indomethacin and Colitis, Granulomatous
| Article | Year |
|---|---|
Control of polyunsaturated acids in tissue lipids.
Topics: Acrodermatitis; alpha-Linolenic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Child; Crohn Dis | 1986 |
38 other studies available for indomethacin and Colitis, Granulomatous
| Article | Year |
|---|---|
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Elemental Diet Regulates Intestinal Permeability and Antibody Production in Indomethacin-Induced Intestinal Injury Rats.
Topics: Animals; Antibody Formation; Crohn Disease; Disease Models, Animal; Food, Formulated; Indomethacin; | 2019 |
GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Disease Models, Animal; Glucagon-Li | 2013 |
Emu oil offers protection in Crohn's disease model in rats.
Topics: Aloe; Animals; Antioxidants; Cecum; Crohn Disease; Disease Models, Animal; Female; Ileum; Indomethac | 2016 |
Effects of Mesalazine on Morphological and Functional Changes in the Indomethacin-Induced Inflammatory Bowel Disease (Rat Model of Crohn's Disease).
Topics: Animals; Crohn Disease; Disease Models, Animal; Glucuronates; Indomethacin; Inflammation; Inflammato | 2017 |
Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats.
Topics: Animals; Crohn Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Comb | 2016 |
GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model.
Topics: Animals; Crohn Disease; Disease Models, Animal; Female; Glucagon-Like Peptide 2; Humans; Indomethaci | 2012 |
A novel human fibroblast growth factor treats experimental intestinal inflammation.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Ce | 2002 |
FGF-20: FGFs--they keep growing and growing and growing!
Topics: Animals; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Disease Models, Animal; Epithelial Cells; | 2003 |
[Effect of mast cell activation on microcirculation of intestinal mucosa in inflamed small intestine of the rat].
Topics: Animals; Blood Flow Velocity; Crohn Disease; Disease Models, Animal; Histamine H1 Antagonists; Hista | 1998 |
[Measuring blood flow velocity in healthy and indomethacin-induced inflammation in rat small intestine serosa with FITC-marked erythrocytes].
Topics: Animals; Blood Flow Velocity; Crohn Disease; Erythrocytes; Indomethacin; Intestinal Mucosa; Leukocyt | 1998 |
Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites.
Topics: Arachidonic Acid; Blotting, Western; Cells, Cultured; Crohn Disease; Cyclooxygenase Inhibitors; Gene | 2004 |
Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model.
Topics: Animals; Crohn Disease; Enteritis; Indomethacin; Inflammation; Intestinal Absorption; Intestine, Sma | 2004 |
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Case-Control Studies; Crohn | 2005 |
An elemental diet controls inflammation in indomethacin-induced small bowel disease in rats: the role of low dietary fat and the elimination of dietary proteins.
Topics: Animals; Crohn Disease; Dietary Proteins; Disease Models, Animal; Food, Formulated; Gastrointestinal | 2005 |
Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butanones; Colitis, Ul | 2006 |
Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?
Topics: Adult; Animals; Case-Control Studies; Colon; Crohn Disease; Dietary Supplements; Disease Models, Ani | 2006 |
Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC.
Topics: Animals; Crohn Disease; Disease Models, Animal; Female; Fibrosis; Immunoenzyme Techniques; Indometha | 2008 |
Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease.
Topics: Animals; Antibodies, Monoclonal; Cell Membrane Permeability; Crohn Disease; Disease Models, Animal; | 2008 |
Increased suppressor cell activity in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Hydrocortisone; In Vitro Technique | 1981 |
Defective lymphocyte IgA production in inflammatory bowel disease.
Topics: Adolescent; Adult; Antibody-Producing Cells; Child; Colitis, Ulcerative; Crohn Disease; Female; Huma | 1982 |
Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Topics: Adult; Aged; Crohn Disease; Dose-Response Relationship, Immunologic; Female; Humans; Indomethacin; L | 1983 |
Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature.
Topics: Adult; Aspirin; Colitis, Ulcerative; Crohn Disease; Humans; Indomethacin; Male; Middle Aged; Pericar | 1983 |
Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
Topics: Cimetidine; Crohn Disease; Humans; Indomethacin; Intestinal Mucosa; Lymphocyte Activation; Lymphocyt | 1982 |
Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.
Topics: Adult; Aged; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Cell Division; Crohn Disease; Dinoprostone; | 1994 |
Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Topics: Adolescent; Cell Division; Child; Colitis, Ulcerative; Colon; Crohn Disease; Flow Cytometry; Humans; | 1993 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy | 1994 |
Selective COX-2 inhibitors and human inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2; Cyclo | 1999 |
Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat.
Topics: Animals; Crohn Disease; Humans; Ileum; Indomethacin; Intestine, Small; Jejunal Diseases; Male; Mesen | 2000 |
The effects of smoking and indomethacin on small intestinal permeability.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Female; Humans; | 2000 |
Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Inflammatory Age | 2001 |
Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Colitis, Ulcerative; Cr | 1991 |
Ocular inflammation in Crohn's disease.
Topics: Adolescent; Adult; Aged; Anterior Eye Segment; Anti-Inflammatory Agents, Non-Steroidal; Child; Colit | 1991 |
[Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Calcimycin; Chromatography | 1986 |
Mitogenic response and interleukin 2 production in Crohn's disease.
Topics: Concanavalin A; Crohn Disease; Humans; Indomethacin; Interleukin-2; Leukocytes, Mononuclear; Lymphoc | 1987 |
Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Cell Fractionation; Cell Line; Cell Nucleus; Coliti | 1985 |
Ankylosing spondylitis.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Arthritis, Juvenile; Arthritis, Reactive; Colitis, Ul | 1968 |
[Clinical observations on the treatment of rheumatic diseases and other morbid states with indomethacin].
Topics: Anemia, Hemolytic, Autoimmune; Arthritis, Rheumatoid; Asthma; Crohn Disease; Dexamethasone; Hodgkin | 1966 |